Insider Cluster (2 insiders) ·Filed Jul 2, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $856K total
Actionable Insight • Neutral

The insider sales are small and likely routine. Monitor for any upcoming earnings or pipeline catalysts that could explain the timing, but the cluster alone does not warrant a bearish stance. The historical calibration shows past neutral reports on XERS had mixed T+20 outcomes, so no strong directional read is justified here.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+60d ⚠ clustered
XERS ▲ +8.09% at T+60d
NEUTRAL call ✓ call won +8.09% · α vs SPY +5.08% · entry $8.28 → $8.95
Next anchor: T+1d due 3mo ago
Entry anchored
Jul 1, 03:59 PM ET
via exchange tick
T+1d
—
call — · α —
—
due 3mo ago
T+5d
+4.11%
call +4.11% · α +3.18%
$8.62
settled 3mo ago
T+20d
+1.69%
call +1.69% · α +2.11%
$8.42
settled 2mo ago
T+60d
+8.09%
call +8.09% · α +5.08%
$8.95
settled 7d ago

Price Chart

Loading chart...

Executive Summary

Two XERS insiders (Kevin McCulloch and Beth Hecht) sold a combined $856K in open-market sales on July 1, 2026, representing ~0.06% of the $1.4B market cap. Director Nerissa Kreher received a non-cash grant and a separate restricted stock award. The sales are small relative to market cap and may be routine portfolio diversification, but the cluster of two C-suite-level insiders selling on the same day warrants attention.

Key Financial Metrics

Direction
selling
Total Value
$856.4K
Insiders
2

Key Facts

  • Two insiders (Kevin McCulloch and Beth Hecht) sold a combined $856K in open-market sales on July 1, 2026.
  • Total sales represent ~0.06% of XERS's $1.4B market cap — well below the 0.1% materiality threshold.
  • Director Nerissa Kreher received a non-cash grant of 33,582 shares and a separate restricted stock award of 37,910 shares valued at $303,280.
  • The cluster is small in dollar terms and may reflect routine portfolio rebalancing or tax planning, not a bearish signal.

Financial Impact

Total insider sales of $856K represent ~0.06% of XERS's $1.4B market cap — immaterial from a proportionality perspective.

insider ownershipfloat

Risk Factors

  • Insider sales, while small, could indicate a lack of conviction ahead of a catalyst event.
  • The stock has rallied significantly in recent weeks (past neutral reports saw +10% T+5 moves), and insiders selling into strength is a common pattern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-XERS-1783063139595
14 reports for XERS
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +24.89%Jun 12, 2026
Filters
Rows
Reports for XERS — sortable, filterable
TypeNow
Sep 9, 2026
23d ago
8-K
BULLISH ★ 6/10
$7.71 $7.78▲ +0.91%▲ +1.56%$9.08 (+17.77%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.58 $7.67▼ −10.61%▼ −9.65%$9.08 (+5.83%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$7.36 $8.33▲ +13.18%▲ +11.97%$9.08 (+23.37%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.19 $8.39▲ +2.44%▲ +2.54%$9.08 (+10.87%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 4/10
$8.94 $8.28▲ +7.38%▲ +7.93%$9.08 (−1.57%)
Jul 2, 2026
13w ago
3
NEUTRAL ★ 3/10
$8.28 $8.62▲ +4.11%▲ +3.18%$9.08 (+9.66%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.28 $8.62▲ +4.11%▲ +3.18%$9.08 (+9.66%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$8.00 $8.94▲ +11.75%▲ +11.49%$9.08 (+13.50%)
Jun 12, 2026
16w ago
Institutional Cluster
BULLISH ★ 4/10
$6.79 $6.95▲ +2.36%▲ +1.68%$9.08 (+33.73%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.24 $6.88▲ +10.26%▲ +8.14%$9.08 (+45.51%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026